Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Padmanabhan, Purnimaa; b | Sreekanth Rao, Keerthanaa; c | Gonzalez, Anthony J.a | Pantelyat, Alexander Y.d | Chib, Vikram S.a; c | Roemmich, Ryan T.a; e; *
Affiliations: [a] Center for Movement Studies, Kennedy Krieger Institute, Baltimore, MD, USA | [b] Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA | [c] Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA | [d] Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA | [e] Departmentof Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Correspondence: [*] Correspondence to: Ryan T. Roemmich, PhD, G-04 Kennedy Krieger Institute, 707 North Broadway, Baltimore, MD 21205, USA. E-mail: [email protected].; Twitter: @RyanRoemmich
Abstract: Background:Gait slowing is a common feature of Parkinson’s disease (PD). Many therapies aim to improve gait speed in persons with PD, but goals are often imprecise. How fast should each patient walk? And how do persons with PD benefit from walking faster? There is an important need to understand how walking speed affects fundamental aspects of gait—including energy cost and stability—that could guide individualized therapy decisions in persons with PD. Objective:We investigated how changes in walking speed affected energy cost and spatiotemporal gait parameters in persons with PD. We compared these effects between dopaminergic medication states and to those observed in age-matched control participants. Methods:Twelve persons with PD and twelve control participants performed treadmill walking trials spanning at least five different speeds (seven speeds were desired, but not all participants could walk at the fastest speeds). Persons with PD participated in two walking sessions on separate days (once while optimally medicated, once after 12-hour withdrawal from dopaminergic medication). We measured kinematic and metabolic data across all trials. Results:Persons with PD significantly reduced energy cost by walking faster than their preferred speeds. This held true across medication conditions and was not observed in control participants. The patient-specific walking speeds that reduced energy cost did not significantly affect gait variability metrics (used as proxies for gait stability). Conclusion:The gait slowing that occurs with PD results in energetically suboptimal walking. Rehabilitation strategies that target patient-specific increases in walking speed could result in a less effortful gait.
Keywords: Gait, Parkinson’s disease, rehabilitation, energy, dopamine
DOI: 10.3233/JPD-212613
Journal: Journal of Parkinson's Disease, vol. 11, no. 4, pp. 2073-2084, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]